placebo-controlled phase of the PREEMPT 2 trial OnabotulinumtoxinA for treatment of chronic migraine: Results from the double-blind, randomized,

A six-item short-form survey for measuring headache impact: The HIT-6™

Mark Kosinski, Martha Bayliss, John E. Ware et al. · Quality of Life Research · 2003 · 1.3K citations

Social Sciences, Educational Assessment, Psychology +14

OnabotulinumtoxinA for treatment of chronic migraine: Results from the double-blind, randomized, placebo-controlled phase of the PREEMPT 1 trial

SK Aurora, DW Dodick, CC Turkel et al. · Cephalalgia · 2010 · 1K citations · Full text

Medicine, Pharmacology, Pharmacotherapy +17

New Appendix Criteria Open for a Broader Concept of Chronic Migraine

Jes Olesen, M.G. Bousser, H-C Diener et al. · Cephalalgia · 2006 · 915 citations

Pharmacy, Pharmacology, Pharmacotherapy +15

Epidemiology of Chronic Daily Headache in the General Population

Jesús Castillo, Pedro Muñoz, Victoria Guitera et al. · Headache The Journal of Head and Face Pain · 1999 · 720 citations · Full text

Medicine, Neurology, Cranial Nerve Disorders +13

Sociodemographic and comorbidity profiles of chronic migraine and episodic migraine sufferers

Dawn C. Buse, AN Manack, Daniel Serrano et al. · Journal of Neurology Neurosurgery & Psychiatry · 2010 · 617 citations · Full text

Education, Neurology, Behavioral Epidemiology +15